123-I mIBG (AdreView) Heart-to-Mediastinal (H/M) Ratio and SPECT Imaging on a Small Field of View-High Efficiency Cardiac SPECT System



Status:Completed
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - 90
Updated:1/13/2018
Start Date:December 2013
End Date:October 2014

Use our guide to learn which trials are right for you!

123-I mIBG (AdreView) Heart-to-Mediastinal (H/M) Ratio and SPECT Imaging

The purpose of this study is to demonstrate correlation of the H/M ratio of AdreView when
derived from a large field of view Anger SPECT system and from a small field of view high
sensitivity (CZT) SPECT system.


Inclusion Criteria:

- New York Heart Association Class II or III Heart Failure

- Left ventricular ejection fraction less than or equal to 35%

Exclusion Criteria:

- Uncompensated heart failure

- Recent hospitalization within 30 days of cardiac related indications
We found this trial at
1
site
Kansas City, Missouri 64111
?
mi
from
Kansas City, MO
Click here to add this to my saved trials